Cravit Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Levofloxacin

Indications/Uses

Acute sinusitis; acute exacerbation of chronic bronchitis; community-acquired & nosocomial pneumonia; complicated & uncomplicated skin & skin structure infection (SSSI); complicated & uncomplicated UTI; chronic bacterial prostatitis; H. pylori infection; pyelonephritis including the acute type. Empiric treatment for community-acquired pneumonia.

Click to view Cravit detailed prescribing information

Dosage/Direction for Use

Acute sinusitis 500 mg once daily for 10-14 days or 750 mg once daily for 5 days. Acute exacerbation of chronic bronchitis 500 mg once daily for 7 days or 750 mg once daily for 5 days. Community-acquired pneumonia 500 mg once daily for 7-14 days or 750 mg once daily for 5 days. Nosocomial pneumonia, complicated skin & skin structure infection (SSSI) 750 mg once daily for 7-14 days. Uncomplicated SSSI 500 mg once daily for 7-10 days. Uncomplicated UTI 250 mg once daily for 3 days. Complicated UTI 250 mg once daily for 10 days or 750 mg once daily for 5 days. Chronic bacterial prostatitis 500 mg once daily for 28 days. H. pylori infection 500 mg once daily for 10 days. Acute pyelonephritis 750 mg once daily for 5 days. Pyelonephritis 250 mg once daily for 10 days. Community-acquired pneumonia 500 mg once daily for 7-14 days or 750 mg once daily for 5 days.

Click to view Cravit detailed prescribing information

Overdosage

View Cravit overdosage for action to be taken in the event of an overdose.

Administration

May be taken with or without food: Take at least 2 hr before or after Fe salts, antacids & sucralfate. Ensure adequate fluid intake.

Contraindications

Hypersensitivity to ofloxacin or other quinolones. Epilepsy, history of tendon disorder related to fluoroquinolones. Childn/adolescents <16 yr. Pregnancy & lactation.

Click to view Cravit detailed prescribing information

Warnings

For additional cautionary notes to warn of the potential risk of using the medicine... Click to view Cravit detailed prescribing information

Special Precautions

Renal impairment, exposure to direct sunlight, known or suspected CNS disorder that may predispose to seizures or lower the seizure threshold, diabetes, serious heart disease, uncorrected electrolyte imbalance, receiving class 1A & III antiarrhythmic agents, myasthenia gravis. Discontinue use if pseudomembranous colitis occurs. Risk of tendonitis & tendon rupture in patient >60 yr, on concomitant corticosteroid & transplant recipients. May impair ability to drive or operate machinery.

Click to view Cravit detailed prescribing information

Use In Pregnancy & Lactation

Click to view Cravit detailed prescribing information

Adverse Reactions

Sleep loss; dizziness, headache; nausea, vomiting, diarrhea, abdominal discomfort; increased AST, ALT, LDH & eosinophil count, decreased WBC count.

Click to view Cravit detailed prescribing information

Drug Interactions

GI absorption interfered w/ Mg- & Al-containing antacids, sucralfate, metal cations & multivit prep w/ zinc. Pronounced lowering of the cerebral seizure threshold may occur w/ theophylline, fenbufen, phenylacetic acid or propionic acid derivatives. Hyperglycemia & hypoglycemia may occur w/ antidiabetic agents. Prolonged prothrombin time of warfarin. Prolonged QT may occur w/ quinidine sulfate, procainamide HCl, amiodarone HCl & sotalol HCl.

Click to view Cravit detailed prescribing information

Storage

View Cravit storage conditions for details to ensure optimal shelf-life.

Description

View Cravit description for details of the chemical structure and excipients (inactive components).

Action

View Cravit mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Quinolones

ATC Classification

J01MA12 - levofloxacin ; Belongs to the class of fluoroquinolones. Used in the systemic treatment of infections.

Regulatory Classification

POM

Presentation/Packing

Form

Cravit FC tab 250 mg

Packing/Price

5's

Form

Cravit FC tab 500 mg

Packing/Price

5's

Form

Cravit FC tab 750 mg

Packing/Price

5's

Form

Cravit soln for infusion 5 mg/mL

Packing/Price

100 mL x 1's;150 mL x 1's;50 mL x 1's

Cravit

levofloxacin

Manufacturer:

Daiichi-Sankyo

Distributor:

Zuellig Pharma